Sunday, 21 April 2024
Zomedica Pharmaceuticals Corp
VSE : ZOM
0.2850 05 Feb 20 00:00 | Change: 0.02 | Open: 0.2850 | High: 0.2850 | Ask: 0.0000 | Volume: 4,800 |
Change(%): 6.56 | Prev: 0.3050 | Low: 0.2850 | Bid: 0.0000 | Avg vol: 0 |
10:11 | 1/3/18
GlobeNewswire
On January 5, 2017, Zomedica announced a research collaboration agreement with Celsee Diagnostics, Inc. (“Celsee”) to test the feasibility of Celsee's liquid biopsy technology for veterinary application as a canine cancer diagnostic.
more»
00:48 | 21/2/18
GlobeNewswire
Based in Ann Arbor, Michigan, Zomedica (NYSE American:ZOM) (TSX-V:ZOM) is a veterinary diagnostic and pharmaceutical company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians ...
more»
06:20 | 22/12/17
Crain's Detroit Business
Zomedica Pharmaceuticals Corp. plans to develop and market technology for diagnosing cancer in animals. The Ann Arbor-based veterinary drug and diagnostic company has agreed to license a blood-testing platform from Celsee Inc., a Plymouth-based cancer ...
more»
00:48 | 22/12/17
GlobeNewswire
ANN ARBOR, Mich., Dec. 21, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary pharmaceutical and diagnostic company, today announced it has entered into a license and supply ...
more»
01:00 | 13/12/17
StreetInsider.com
Zomedica Pharmaceuticals Corp. (NYSE: ZOM), a veterinary pharmaceutical and diagnostic company, today announced a development update on the Company's four therapeutic candidates for use in companion animals, namely dogs and cats.
more»
There are currently no comments on this topic.
Be the first person to Add a Comment...
You must be a registered user to post a comment: REGISTER NOW
If you are already registered, please LOGIN NOW
|
Code | Last | Change |
COMP | 10,321 | 328 | | 3.08% |
DJI | 29,635 | 404 | | 1.34% |
SP500 | 3,583 | 87 | | 2.37% |
DAX | 12,438 | 82 | | 0.67% |
FTSE | 7,488 | 5 | | 0.07% |
NI225 | 22,420 | 408 | | 1.86% |
TWI | 67.27 | 0.00 | | 0.00% |